Faculty Books In Brief—Spring 2016

“FDA in the 21st Century: The Challenges of Regulating Drugs and New Technologies,” edited by Holly Fernandez Lynch and I. Glenn Cohen ’03 (Columbia). Stemming from a 2013 conference at HLS, the book features essays covering major developments that have changed how the FDA regulates; how the agency encourages transparency; First Amendment issues; access to drugs; and evolving issues in drug-safety communication. These issues, the editors write, lie “at the heart of our health and health care.”

Harvard Law School launches the Campaign for the Third Century

With a nod to its historic past and a look ahead to its future, Harvard Law School has formally launched the Campaign for the Third Century, which seeks to raise $305 million in support of students and faculty, clinical education, new and innovative research, and the continued enhancement of the Law School campus.

Emerging mobile health technologies need FDA oversight

Smart phones and other mobile devices have the potential to transform healthcare, improving medical outcomes, reducing errors, and broadening access to healthcare. The Food and Drug Administration must continue to have jurisdiction over these “mobile health” or “mHealth” innovations to address emerging risks, according to I. Glenn Cohen, Nathan G. Cortez, and Aaron S. Kesselheim, […]

‘Choosing not to choose’: improving healthcare law by acknowledging how people behave (video)

Cass Sunstein opened the 2014 Behavioral Economics, Law, and Health Policy Conference with a keynote address called “Choosing Not to Choose.” His talk set the tone for the two-day conference organized by The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, which drew nearly 200 lawyers, public health professionals, economists, and health policy analysts to the campus from May 2-3.